All Pharma News
FogPharma, ARTBIO Collaborate On Helicon Alpha-Particle Radioligand Therapies

FogPharma, ARTBIO Collaborate On Helicon Alpha-Particle Radioligand Therapies
BUSINESSWIRE
14 May 2024
Share Share
FogPharma, ARTBIO Partner to Develop Helicon-Enabled ARTs (HEARTs)

FogPharma, ARTBIO Partner to Develop Helicon-Enabled ARTs (HEARTs)
BUSINESSWIRE
14 May 2024
Share Share
FogPharma Announces $145 Million Financing

FogPharma Announces $145 Million Financing
BUSINESSWIRE
01 Mar 2024
Share Share
FogPharma clears $145M series E thanks to Borisy, ex-J&J CEO

FogPharma clears $145M series E thanks to Borisy, ex-J&J CEO
Max Bayer FIERCE BIOTECH
01 Mar 2024
Share Share
FogPharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference

FogPharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BUSINESSWIRE
04 Jan 2024
Share Share
FogPharma Announces First Patient Dosed in Phase 1/2 Clinical Trial of FOG-001

FogPharma Announces First Patient Dosed in Phase 1/2 Clinical Trial of FOG-001
BUSINESSWIRE
05 Jun 2023
Share Share
Mathai Mammen to Join FogPharma as Chairman

Mathai Mammen to Join FogPharma as Chairman
BUSINESSWIRE
30 Mar 2023
Share Share
FogPharma hauls in $178M series D

FogPharma hauls in $178M series D
Max Bayer FIERCEBIOTECH
21 Nov 2022
Share Share
FogPharma Announces $178 Million Series D Financing to Advance Pipeline

FogPharma Announces $178 Million Series D Financing to Advance Pipeline
BUSINESSWIRE
21 Nov 2022
Share Share
FogPharma Selects Clinical Development Candidate Directly Targeting ?-Catenin

FogPharma Selects Clinical Development Candidate Directly Targeting ?-Catenin
BUSINESSWIRE
09 Mar 2022
Share Share